ATE391136T1 - Fas peptide und antikörper zur modulierung von apoptosis - Google Patents
Fas peptide und antikörper zur modulierung von apoptosisInfo
- Publication number
- ATE391136T1 ATE391136T1 AT99931070T AT99931070T ATE391136T1 AT E391136 T1 ATE391136 T1 AT E391136T1 AT 99931070 T AT99931070 T AT 99931070T AT 99931070 T AT99931070 T AT 99931070T AT E391136 T1 ATE391136 T1 AT E391136T1
- Authority
- AT
- Austria
- Prior art keywords
- antibodies
- fas
- peptides
- modulating apoptosis
- cellular proliferation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9813194.9A GB9813194D0 (en) | 1998-06-18 | 1998-06-18 | Methods and means for modulating apoptosis |
| GBGB9905793.7A GB9905793D0 (en) | 1998-06-18 | 1999-03-12 | Methods and means for modulating apoptosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE391136T1 true ATE391136T1 (de) | 2008-04-15 |
Family
ID=26313898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99931070T ATE391136T1 (de) | 1998-06-18 | 1999-06-15 | Fas peptide und antikörper zur modulierung von apoptosis |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6846637B1 (de) |
| EP (1) | EP1087993B1 (de) |
| AT (1) | ATE391136T1 (de) |
| AU (1) | AU4772299A (de) |
| DE (1) | DE69938451T2 (de) |
| DK (1) | DK1087993T3 (de) |
| ES (1) | ES2306515T3 (de) |
| PT (1) | PT1087993E (de) |
| WO (1) | WO1999065935A2 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003099845A2 (en) | 2002-05-23 | 2003-12-04 | Trustees Of The University Of Pennsylvania | Fas peptide mimetics and uses thereof |
| EP2322559A3 (de) | 2002-07-04 | 2011-08-03 | Patrys Limited | Neoplasma-spezifische Antikörper und deren Verwendungen |
| DE10311248A1 (de) | 2003-03-14 | 2004-09-30 | Müller-Hermelink, Hans Konrad, Prof. Dr. | Humaner monoklonaler Antikörper |
| US7592143B2 (en) * | 2003-04-18 | 2009-09-22 | Cytovia, Inc. | Methods of treating diseases responsive to induction of apoptosis and screening assays |
| EP2343321A1 (de) * | 2003-11-12 | 2011-07-13 | Patrys Limited | Humane karzinomspezifische Antikörper |
| EP1531162A1 (de) | 2003-11-14 | 2005-05-18 | Heinz Vollmers | Antikörper SAM-6, der spezifisch von Adenocarzinom ist, und dessen Verwendungen |
| DE10353175A1 (de) | 2003-11-14 | 2005-06-16 | Müller-Hermelink, Hans Konrad, Prof. Dr. | Humaner monoklonaler Antikörper mit fettsenkender Wirkung |
| US7759077B2 (en) | 2005-08-02 | 2010-07-20 | Shariat Shahrokh F | Soluble fas urinary marker for the detection of bladder transitional cell carcinoma |
| US9309320B2 (en) | 2006-12-28 | 2016-04-12 | Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts | Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo |
| US20110189194A1 (en) * | 2008-07-14 | 2011-08-04 | Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts | Use of cd95 inhibitors for the treatment of inflammatory disorders |
| AU2010223569A1 (en) * | 2009-03-12 | 2011-11-03 | Imed Ab | Human antibodies against human Fas and their use |
| JP6297552B2 (ja) | 2012-07-18 | 2018-03-20 | アポジェニックス アーゲー | Mdsの治療のための、cd95シグナル伝達経路阻害剤 |
| CA2922704A1 (en) | 2013-05-24 | 2014-11-27 | Neil R. Cashman | Cell senescence markers as diagnostic and therapeutic targets |
| EP2898896A1 (de) | 2014-01-22 | 2015-07-29 | Université Pierre et Marie Curie (Paris 6) | Mittel zur Verwendung bei der Behandlung von Netzhautentzündung |
| EP3131922B1 (de) * | 2014-04-17 | 2020-05-13 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Polypeptide und verwendungen davon zur verringerung von cd95-vermittelter zellmotilität |
| EP3076179A1 (de) | 2015-03-30 | 2016-10-05 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Diagnose und behandlung von minderwertigen glioma |
| US11142548B2 (en) | 2016-05-10 | 2021-10-12 | Sorbonne Universite | Agents that activate CD47 and their use in the treatment of inflammation |
| CN114269370A (zh) | 2019-03-29 | 2022-04-01 | 迈斯特治疗公司 | 离体产生t细胞治疗剂的方法以及相关的组合物和方法 |
| IL293350A (en) | 2019-11-27 | 2022-07-01 | Myst Therapeutics Llc | Method of producing tumor-reactive t cell composition using modulatory agents |
| EP4110799B1 (de) | 2020-02-27 | 2024-11-06 | Turnstone Biologics Corp. | Verfahren zur ex-vivo-anreicherung und vermehrung von tumorreaktiven t-zellen und verwandten zusammensetzungen davon |
| WO2026044087A1 (en) | 2024-08-21 | 2026-02-26 | Shape Therapeutics Inc. | Increased cellular stability for aav production |
| WO2026073032A1 (en) | 2024-09-27 | 2026-04-02 | Shape Therapeutics Inc. | Constructs for improved aav production |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69009497T2 (de) | 1990-01-19 | 1994-11-24 | German Cancer Research Center, 6900 Heidelberg | Mit zellularer apoptosis assoziiertes zelloberflächenantigen. |
| CA2067031C (en) | 1991-04-26 | 2003-02-18 | Shigekazu Nagata | Dna coding for human cell surface antigen |
| US5891434A (en) | 1991-06-17 | 1999-04-06 | Centocor, Inc. | Monoclonal antibodies to the APO-1 antigen |
| US5830469A (en) | 1993-10-14 | 1998-11-03 | Immunex Corporation | Fas antagonists and uses thereof |
| NZ275711A (en) | 1993-10-14 | 1998-03-25 | Immunex Corp | Monoclonal antibodies and binding proteins which bind to human fas antigen (nerve growth factor/tumour necrosis factor receptor type) |
| US5663070A (en) * | 1993-11-15 | 1997-09-02 | Lxr Biotechnology Inc. | Recombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TM |
| CA2158822C (en) | 1994-09-27 | 2008-12-23 | Kusuki Nishioka | Therapeutic agent for rheumatic disease |
| JPH08157500A (ja) * | 1994-12-08 | 1996-06-18 | Oriental Yeast Co Ltd | Fas抗原の定量法 |
| WO1997012632A1 (en) | 1995-10-05 | 1997-04-10 | Tkb Associates Limited Partnership | Methods for treatment of diseases associated with a deficiency of fas ligand activity |
| DE19544332C2 (de) * | 1995-11-28 | 1999-07-08 | Deutsches Krebsforsch | Verfahren zum Nachweis der Expression von CD95 Ligand in Zellen |
| JP3663243B2 (ja) * | 1995-12-14 | 2005-06-22 | 株式会社医学生物学研究所 | Fas抗原の免疫学的測定法及び測定用キット |
| AU724579B2 (en) | 1996-04-01 | 2000-09-28 | Sankyo Company Limited | Anti-Fas recombinant antibodies and DNA therefor |
| US5912168A (en) * | 1996-08-30 | 1999-06-15 | Genesis Research & Development Corporation Limited | CD95 regulatory gene sequences |
| AU736287B2 (en) | 1997-03-21 | 2001-07-26 | Sankyo Company Limited | Humanized anti-human Fas antibody |
| AU734758B2 (en) * | 1997-04-01 | 2001-06-21 | Sankyo Company Limited | Anti-fas antibodies |
| AU757961B2 (en) | 1998-09-30 | 2003-03-13 | Sankyo Company Limited | Anti-Fas antibodies |
| KR20020008197A (ko) | 1999-05-24 | 2002-01-29 | 가와무라 요시부미 | 항-Fas 항체를 함유하는 의약 조성물 |
-
1999
- 1999-06-15 WO PCT/EP1999/004105 patent/WO1999065935A2/en not_active Ceased
- 1999-06-15 AU AU47722/99A patent/AU4772299A/en not_active Abandoned
- 1999-06-15 DK DK99931070T patent/DK1087993T3/da active
- 1999-06-15 US US09/719,646 patent/US6846637B1/en not_active Expired - Fee Related
- 1999-06-15 EP EP99931070A patent/EP1087993B1/de not_active Revoked
- 1999-06-15 ES ES99931070T patent/ES2306515T3/es not_active Expired - Lifetime
- 1999-06-15 AT AT99931070T patent/ATE391136T1/de active
- 1999-06-15 PT PT99931070T patent/PT1087993E/pt unknown
- 1999-06-15 DE DE69938451T patent/DE69938451T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69938451D1 (de) | 2008-05-15 |
| DE69938451T2 (de) | 2009-04-09 |
| WO1999065935A2 (en) | 1999-12-23 |
| DK1087993T3 (da) | 2008-07-14 |
| EP1087993B1 (de) | 2008-04-02 |
| US6846637B1 (en) | 2005-01-25 |
| AU4772299A (en) | 2000-01-05 |
| PT1087993E (pt) | 2008-07-04 |
| EP1087993A1 (de) | 2001-04-04 |
| WO1999065935A3 (en) | 2003-04-17 |
| ES2306515T3 (es) | 2008-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69938451D1 (de) | Fas peptide und antikörper zur modulierung von apoptosis | |
| IL130036A0 (en) | Survivin a protein that inhibits cellular apoptosis and its modulation | |
| EP1019365A4 (de) | Zubereitungen zur abgabe von negativ geladenen molekülen | |
| NO20000934D0 (no) | Adipocyttspesifikke proteinhomologer | |
| DE60041452D1 (de) | CpG REZEPTOR (CpG-R) UND DARAUF BEZOGENE METHODEN | |
| MXPA04002808A (es) | Acidos nucleicos receptores de ecdisona de mosca blanca, polipeptidos, y sus usos. | |
| DE69833014D1 (de) | Menschliche toll homologen | |
| CA2321177A1 (en) | Recombinant fibronectin-based extracellular matrix for wound healing | |
| DE502005009389D1 (de) | Identifizierung und charakterisierung von funktionsblockierenden anti-ed-b-fibronektin antikörpern | |
| PL338139A1 (en) | Protein homologues specific for adipocytes | |
| EP1517144A3 (de) | Verfahren zur Identifizierung eines Antikörpers, der einen humanen Vanilloid Rezeptor bindet und dessen Aktivität moduliert | |
| ATE311443T1 (de) | Methoden zur durchforstung (screenen) von proteinen | |
| NZ514091A (en) | Vascular adhesion molecules and modulation of their function | |
| MXPA02011002A (es) | Oligopeptidos para promover el crecimiento del cabello. | |
| ATE240349T1 (de) | Peptide zur inhibierung von hpv e6-proteinen | |
| WO2004109290A3 (en) | Methods for identifying modulators of kinesin activity | |
| WO2002090544A3 (en) | Protein-protein interactions in adipocyte cells (3) | |
| DE69939593D1 (de) | Polypeptide zur modulierung des überlebens von zellen | |
| BR0207253A (pt) | Polinucleotìdeo, polipeptìdeo isolado, anticorpo monoclonal, ou fragmento de ligação do antìgeno do mesmo, vetor de expressão, célula hospedeira, medicamento composição farmacêutica, e, utilização de um polipeptìdio isolado | |
| DE60333669D1 (de) | Verfahren und zusammensetzungen zur modulation und zum nachweis von wisp-aktivität | |
| CY1109378T1 (el) | Fas πεπτιδια και αντισωματα για ρυθμιση αποπτωσης | |
| DE60120507D1 (de) | Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1 | |
| EP2236619A3 (de) | BCL2L12-Polypeptidaktivatoren und -inhibitoren | |
| DE69806107D1 (de) | Methoden und reagenzien zur regulierung von apoptosis | |
| WO2003075014A3 (en) | Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1087993 Country of ref document: EP |